Search Press releases Keywords From To 10 Jun 2024 Global experts release new guidelines on prevention of progression of epileptic seizures, addressing critical treatment gaps Read More 7 Jun 2024 Acquisition of own shares Read More 31 May 2024 Acquisition of own shares Read More 31 May 2024 UCB announces positive CHMP opinion for 320 mg device presentations of BIMZELX[®]▼ (bimekizumab) Read More 24 May 2024 Acquisition of own shares Read More 23 May 2024 UCB announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa Read More Pagination First page Previous page Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
